| Molecular recognition of insulin by a synthetic receptor JM Chinai, AB Taylor, LM Ryno, ND Hargreaves, CA Morris, PJ Hart, ... Journal of the American Chemical Society 133 (23), 8810-8813, 2011 | 329 | 2011 |
| Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma P Koirala, ME Roth, J Gill, S Piperdi, JM Chinai, DS Geller, BH Hoang, ... Scientific reports 6 (1), 30093, 2016 | 261 | 2016 |
| HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function R Zhao, JM Chinai, S Buhl, L Scandiuzzi, A Ray, H Jeon, KC Ohaegbulam, ... Proceedings of the National Academy of Sciences 110 (24), 9879-9884, 2013 | 222 | 2013 |
| New immunotherapies targeting the PD-1 pathway JM Chinai, M Janakiram, F Chen, W Chen, M Kaplan, X Zang Trends in pharmacological sciences 36 (9), 587-595, 2015 | 219 | 2015 |
| Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein M Janakiram, JM Chinai, S Fineberg, A Fiser, C Montagna, ... Clinical cancer research 21 (10), 2359-2366, 2015 | 158 | 2015 |
| HHLA2, a new immune checkpoint member of the B7 family, is widely expressed in human lung cancer and associated with EGFR mutational status H Cheng, M Janakiram, A Borczuk, J Lin, W Qiu, H Liu, JM Chinai, ... Clinical Cancer Research 23 (3), 825-832, 2017 | 115 | 2017 |
| HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families M Janakiram, JM Chinai, A Zhao, JA Sparano, X Zang Oncoimmunology 4 (8), e1026534, 2015 | 115 | 2015 |
| HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival P Koirala, ME Roth, J Gill, JM Chinai, MR Ewart, S Piperdi, DS Geller, ... Scientific reports 6 (1), 31154, 2016 | 91 | 2016 |
| Structure and cancer immunotherapy of the B7 family member B7x H Jeon, V Vigdorovich, SC Garrett-Thomson, M Janakiram, ... Cell reports 9 (3), 1089-1098, 2014 | 86 | 2014 |
| KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target Y Wei, X Ren, PM Galbo Jr, S Moerdler, H Wang, RA Sica, ... Science immunology 6 (61), eabf9792, 2021 | 58 | 2021 |
| Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma. Sci Rep. 2016; 6: 30093 P Koirala, ME Roth, J Gill, S Piperdi, JM Chinai, DS Geller, BH Hoang, ... Epub 2016/07/28. PubMed Central PMCID: PMCPMC4960483. https://doi. org/10 …, 0 | 11 | |
| The use of Bcl-2 over-expression to stabilize hybridomas specific to the HERG potassium channel J Sroubek, Y Krishnan, J Chinai, S Buhl, MD Scharff, TV McDonald Journal of immunological methods 375 (1-2), 215-222, 2012 | 8 | 2012 |
| TMIGD2 AND ITS DERIVATIVES AS BLOCKERS OR BINDERS OF CANCER-EXPRESSED HHLA2 FOR IMMUNOTHERAPIES X Zang, JM Chinai, M Janakiram, SC Almo, A Fiser US Patent App. 18/405,839, 2024 | | 2024 |
| Tmigd2 and its derivatives as blockers or binders of cancer-expressed hhla2 for immunotherapies X Zang, JM Chinai, M Janakiram, SC Almo, A Fiser US Patent App. 17/140,996, 2021 | | 2021 |
| TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapies X Zang, JM Chinai, M Janakiram, SC Almo, A Fiser US Patent 10,882,893, 2021 | | 2021 |
| TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapies X Zang, JM Chinai, M Janakiram, SC Almo, A Fiser US Patent 10,280,208, 2019 | | 2019 |
| Abstract A180: HHLA2 is a novel tumor-expressed member of the B7 immune checkpoint family JM Chinai, H Wang, X Tang, M Janakiram, H Cheng, X Zang Cancer Immunology Research 7 (2_Supplement), A180-A180, 2019 | | 2019 |
| OA20. 07 HHLA2, a New Immune Checkpoint Member of the B7 Family, is Widely Expressed in Human Lung Cancer and Associated with Mutational Status H Cheng, M Janakiram, A Borczuk, J Lin, W Qiu, H Liu, J Chinai, ... Journal of Thoracic Oncology 12 (1), S325-S326, 2017 | | 2017 |
| HHLA2 and TMIGD2 are two novel members of the B7-CD28 immune checkpoint family JM Chinai ProQuest Dissertations & Theses, 2017 | | 2017 |
| HHLA2, a New Immune Checkpoint Member of the B7 Family, is Widely Expressed in Human Lung Cancer and Associated with Mutational Status H Cheng, M Janakiram, A Borczuk, J Lin, W Qiu, H Liu, J Chinai, ... JOURNAL OF THORACIC ONCOLOGY 12 (1), S325-S326, 2017 | | 2017 |
